Effective High Aerobic Intensity Endurance Training Regimes in Chronic Obstructive Pulmonary Disease (COPD) Patients
This study has been completed.
Sponsor:
Norwegian University of Science and Technology
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00658853
First received: April 10, 2008
Last updated: April 14, 2008
Last verified: April 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
4 times 4 minutes interval training with and without hyperoxia is more effective than low intensity endurance training.
| Condition | Intervention |
|---|---|
|
Pulmonary Disease, Chronic Obstructive Hyperoxia |
Behavioral: 4 times 4 minutes high aerobic intensity one leg cycling |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effective High Aerobic Intensity Interval Training to Improve Maximal Oxygen Uptake in COPD Patients |
Resource links provided by NLM:
Further study details as provided by Norwegian University of Science and Technology:
Primary Outcome Measures:
- VO2peak [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
- Ventilation [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
- FEV1 [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
- Walking performance [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Quality of life [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- SPSS [ Time Frame: 3 months ] [ Designated as safety issue: No ]
| Enrollment: | 26 |
| Study Start Date: | January 2004 |
| Study Completion Date: | February 2006 |
| Primary Completion Date: | February 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1
High aerobic intensity treadmill walking. 4 by 4 minutes interval training on a 5% graded treadmill at a heart rate corresponding to 85-95% of maximal heart rate. 3 times per week for 10 weeks.
|
Behavioral: 4 times 4 minutes high aerobic intensity one leg cycling
3 times per week for 10 weeks
|
|
Active Comparator: 2
4 times 4 minutes interval training in hyperoxia - 100% oxygen
|
Behavioral: 4 times 4 minutes high aerobic intensity one leg cycling
3 times per week for 10 weeks
|
|
Active Comparator: 3
One leg at a time training 4 times 4 minutes interval training using cycling ergometer
|
Behavioral: 4 times 4 minutes high aerobic intensity one leg cycling
3 times per week for 10 weeks
|
Eligibility| Ages Eligible for Study: | 20 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- COPD
Exclusion Criteria:
- Heart disease
- Walking or cycling inabilities
- Other diseases
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00658853
Locations
| Norway | |
| Norwegian University of Science and Technology | |
| Trondheim, Norway, NO-7489 | |
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
| Principal Investigator: | Jan Helgerud, PhD | Norwegian University of Science and Technology |
More Information
No publications provided
| Responsible Party: | Professor Jan Helgerud / Assoc. Prfessor Sigurd Steinshamn, Norwegian University of Science and Technology |
| ClinicalTrials.gov Identifier: | NCT00658853 History of Changes |
| Other Study ID Numbers: | 149-03 |
| Study First Received: | April 10, 2008 |
| Last Updated: | April 14, 2008 |
| Health Authority: | Norway: Norwegian Social Science Data Services |
Keywords provided by Norwegian University of Science and Technology:
|
COPD training VO2peak performance |
ventilation high aerobic intensity treadmill walking one leg training by cycling |
Additional relevant MeSH terms:
|
Chronic Disease Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Hyperoxia Lung Diseases, Obstructive |
Disease Attributes Pathologic Processes Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on June 18, 2013